Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan

Summary

Scholar Rock provided an update on the global regulatory progress of apitegromab across the U.S., Europe, and Japan. The article does not contain specific details about outcomes, timelines, or clinical results.